Provided by Tiger Trade Technology Pte. Ltd.

Fractyl Health

4.23
-0.2900-6.42%
Post-market: 4.300.0700+1.65%19:30 EDT
Volume:300.54K
Turnover:1.28M
Market Cap:55.92M
PE:-0.31
High:4.53
Open:4.50
Low:4.14
Close:4.52
52wk High:29.34
52wk Low:4.14
Shares:13.22M
Float Shares:10.67M
Volume Ratio:1.18
T/O Rate:2.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.4316
EPS(LYR):-22.3200
ROE:-778.33%
ROA:-74.57%
PB:-33.59
PE(LYR):-0.19

Loading ...

Fractyl Health Announces Special Stockholder Meeting

Reuters
·
Aug 15

UK's Mereo BioPharma Q2 Loss Narrows on Lower R&D Spending

Reuters
·
Aug 11

Morgan Stanley Keeps Their Hold Rating on Fractyl Health, Inc. (GUTS)

TIPRANKS
·
Aug 11

Fractyl Health, Inc. (GUTS) Receives a Buy from Bank of America Securities

TIPRANKS
·
Aug 11

Fractyl Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Fractyl Health reports Q2 EPS (16c), consensus (14c)

TIPRANKS
·
Aug 11

Palisade Bio Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 11

Fractyl Health Q2 FY26 Net Loss Narrows to $25.5 Million; Adjusted Ebitda Loss Improves to $16.3 Million

Reuters
·
Aug 11

Fractyl Health Q2 EPS $(0.16) Misses $(0.13) Estimate

Benzinga Earnings
·
Aug 11

Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates

GlobeNewswire
·
Aug 11

Fractyl Health, Inc. Expected to Post a Loss of 13 Cents a Share - Earnings Preview

Reuters
·
Aug 07

Fractyl Health to Report Q2 Results, Host Conference Call

Reuters
·
Aug 04

Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026

THOMSON REUTERS
·
Aug 04

Fractyl Health to Participate in Upcoming Investor Events

GlobeNewswire
·
Jul 23

Hold Rating Reaffirmed as Revita Data Show Promise but Risks and Valuation Keep Price Target Unchanged at $2

TIPRANKS
·
Jul 16

Analysts Are Bullish on Top Healthcare Stocks: Fractyl Health, Inc. (GUTS), AbbVie (ABBV)

TIPRANKS
·
Jul 16

Fractyl Health reports results from REMAIN-1 Midpoint Cohort

TIPRANKS
·
Jul 15

Fractyl Health Says Revita Cuts Weight Regain vs Sham One Year After GLP-1 Discontinuation in Remain-1 Trial

Reuters
·
Jul 15

Fractyl Health - no Device-related Serious Adverse Events Reported; Teae Rates Similar Between Groups

THOMSON REUTERS
·
Jul 15

Fractyl Health - Topline Six-month Remain-1 Data Expected Early Q4 2026; FDA Submission Planned Late Q4 2026

THOMSON REUTERS
·
Jul 15